title: Targeting the RANKL pathway: putting the brakes on prostate cancer progression in bone.
authors.affiliation: Jonsson Comprehensive Cancer Center; David Geffen School of Medicine; Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles; and Greater Los Angeles Veterans Affairs Medical Center, Los Angeles, CA.
authors.forename: Isla P
authors.initials: IP
authors.lastname: Garraway
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001859:Bone Neoplasms / Q000556:secondary*; D018450:Disease Progression; D006801:Humans; D008297:Male; D008875:Middle Aged; D010010:Osteoclasts / Q000187:drug effects; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000378:metabolism* / Q000473:pathology*; D053245:RANK Ligand / Q000187:drug effects / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects
chemical_list: D053245:RANK Ligand; D017430:Prostate-Specific Antigen